PI3K/Akt in platelet integrin signaling and implications in thrombosis - PubMed (original) (raw)
Review
PI3K/Akt in platelet integrin signaling and implications in thrombosis
Gianni F Guidetti et al. Adv Biol Regul. 2015 Sep.
Abstract
Blood platelets are anucleated circulating cells that play a critical role in hemostasis and are also implicated in arterial thrombosis, a major cause of death worldwide. The biological function of platelets strongly relies in their reactiveness to a variety of extracellular agonists that regulate their adhesion to extracellular matrix at the site of vascular injury and their ability to form rapidly growing cell aggregates. Among the membrane receptors expressed on the cell surface, integrins are crucial for both platelet activation, adhesion and aggregation. Integrin affinity for specific ligands is regulated by intracellular signaling pathways activated in stimulated platelets, and, once engaged, integrins themselves generate and propagate signals inside the cells to reinforce and consolidate platelet response and thrombus formation. Phosphatidylinositol 3-Kinases (PI3Ks) have emerged as crucial players in platelet activation, and they are directly implicated in the regulation of integrin function. This review will discuss the contribution of PI3Ks in platelet integrin signaling, focusing on the role of specific members of class I PI3Ks and their downstream effector Akt on both integrin inside-out and outside-in signaling. The contribution of the PI3K/Akt pathways stimulated by integrin engagement and platelet activation in thrombus formation and stabilization will also be discussed in order to highlight the possibility to target these enzymes in effective anti-thrombotic therapeutic strategies.
Keywords: Adhesion; Aggregation; Integrins; Platelets; Thrombus formation.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
- ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β.
O'Brien KA, Gartner TK, Hay N, Du X. O'Brien KA, et al. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2232-40. doi: 10.1161/ATVBAHA.112.254680. Epub 2012 Jul 19. Arterioscler Thromb Vasc Biol. 2012. PMID: 22814751 Free PMC article. - Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
Seizer P, Ungern-Sternberg SN, Schönberger T, Borst O, Münzer P, Schmidt EM, Mack AF, Heinzmann D, Chatterjee M, Langer H, Malešević M, Lang F, Gawaz M, Fischer G, May AE. Seizer P, et al. Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):655-63. doi: 10.1161/ATVBAHA.114.305112. Epub 2014 Dec 30. Arterioscler Thromb Vasc Biol. 2015. PMID: 25550208 - Class I PI 3-kinases signaling in platelet activation and thrombosis: PDK1/Akt/GSK3 axis and impact of PTEN and SHIP1.
Laurent PA, Severin S, Gratacap MP, Payrastre B. Laurent PA, et al. Adv Biol Regul. 2014 Jan;54:162-74. doi: 10.1016/j.jbior.2013.09.006. Epub 2013 Sep 18. Adv Biol Regul. 2014. PMID: 24095650 Review. - Platelet receptors and signaling in the dynamics of thrombus formation.
Rivera J, Lozano ML, Navarro-Núñez L, Vicente V. Rivera J, et al. Haematologica. 2009 May;94(5):700-11. doi: 10.3324/haematol.2008.003178. Epub 2009 Mar 13. Haematologica. 2009. PMID: 19286885 Free PMC article. Review. - The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling.
Borst O, Münzer P, Gatidis S, Schmidt EM, Schönberger T, Schmid E, Towhid ST, Stellos K, Seizer P, May AE, Lang F, Gawaz M. Borst O, et al. Circ Res. 2012 Oct 26;111(10):1297-307. doi: 10.1161/CIRCRESAHA.112.276444. Epub 2012 Aug 27. Circ Res. 2012. PMID: 22927331
Cited by
- MALAT1 promotes platelet activity and thrombus formation through PI3k/Akt/GSK-3β signalling pathway.
Sun Y, Wang T, Lv Y, Li J, Jiang X, Jiang J, Zhang D, Bian W, Zhang C. Sun Y, et al. Stroke Vasc Neurol. 2023 Jun;8(3):181-192. doi: 10.1136/svn-2022-001498. Epub 2022 Oct 14. Stroke Vasc Neurol. 2023. PMID: 36241224 Free PMC article. - Daidzein Inhibits Human Platelet Activation by Downregulating Thromboxane A2 Production and Granule Release, Regardless of COX-1 Activity.
Hong HJ, Nam GS, Nam KS. Hong HJ, et al. Int J Mol Sci. 2023 Jul 26;24(15):11985. doi: 10.3390/ijms241511985. Int J Mol Sci. 2023. PMID: 37569361 Free PMC article. - DMAG, a novel countermeasure for the treatment of thrombocytopenia.
Lin J, Zeng J, Liu S, Shen X, Jiang N, Wu YS, Li H, Wang L, Wu JM. Lin J, et al. Mol Med. 2021 Nov 27;27(1):149. doi: 10.1186/s10020-021-00404-1. Mol Med. 2021. PMID: 34837956 Free PMC article. - Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases.
Mancinelli R, Carpino G, Petrungaro S, Mammola CL, Tomaipitinca L, Filippini A, Facchiano A, Ziparo E, Giampietri C. Mancinelli R, et al. Oxid Med Cell Longev. 2017;2017:4629495. doi: 10.1155/2017/4629495. Epub 2017 Dec 12. Oxid Med Cell Longev. 2017. PMID: 29379583 Free PMC article. Review. - Tannins as Hemostasis Modulators.
Marcińczyk N, Gromotowicz-Popławska A, Tomczyk M, Chabielska E. Marcińczyk N, et al. Front Pharmacol. 2022 Jan 13;12:806891. doi: 10.3389/fphar.2021.806891. eCollection 2021. Front Pharmacol. 2022. PMID: 35095516 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical